Ignite Creation Date:
2024-05-06 @ 9:16 AM
Last Modification Date:
2024-10-26 @ 12:12 PM
Study NCT ID:
NCT02949089
Status:
COMPLETED
Last Update Posted:
2016-10-31
First Post:
2011-05-03
Brief Title:
ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects
Sponsor:
Ache Laboratorios Farmaceuticos SA
Organization:
Ache Laboratorios Farmaceuticos SA
Study Overview
Official Title:
An Open Label Dose Escalation Study of ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study intends to provide information on the safety and tolerability of repeated oral doses of ACH04 A phase I single-center first in human open-label dose escalation study of ACH04 to assess the safety and tolerability in healthy adults subjects is selected to best address the study goals
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None